Difference between revisions of "EYE5:Volunteer Assignments and Opportunities"
Jump to navigation
Jump to search
[checked revision] | [checked revision] |
(5 intermediate revisions by the same user not shown) | |||
Line 6: | Line 6: | ||
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest. | To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest. | ||
− | + | __TOC__ | |
<br /> | <br /> | ||
{| class="wikitable" style="margin:auto" | {| class="wikitable" style="margin:auto" | ||
Line 18: | Line 18: | ||
!'''Date of Last Editor Review''' | !'''Date of Last Editor Review''' | ||
!'''Notes''' | !'''Notes''' | ||
− | |- | | + | |- |
+ | | | ||
+ | ==== CHAPTER 2 (TUMOURS OF THE CONJUCTIVA AND CARUNCLE) ==== | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | |- | ||
+ | |[[EYE5:Epithelial_conjunctival_inclusion_cyst|Epithelial conjunctival inclusion cyst]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Reactive_epithelial_hyperplasia_of_the_conjunctiva|Reactive epithelial hyperplasia of the conjunctiva]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Papillary_and_follicular_conjunctivitis|Papillary and follicular conjunctivitis]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Pterygium_and_pingueculum|Pterygium and pingueculum]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Epibulbar_choristoma_(dermoid;_dermolipoma;_complex_choristoma)|Epibulbar choristoma (dermoid; dermolipoma; complex choristoma)]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Epibulbar_osseous_choristoma|Epibulbar osseous choristoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Conjunctival_squamous_cell_papilloma|Conjunctival squamous cell papilloma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Conjunctival_oncocytoma|Conjunctival oncocytoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Hereditary_benign_intraepithelial_dyskeratosis|Hereditary benign intraepithelial dyskeratosis]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Conjunctival_squamous_intraepithelial_neoplasia|Conjunctival squamous intraepithelial neoplasia]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Conjunctival_squamous_cell_carcinoma|Conjunctival squamous cell carcinoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Adenosquamous_carcinoma|Adenosquamous carcinoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Benign_epithelial_melanosis_of_the_conjunctiva|Benign epithelial melanosis of the conjunctiva]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Junctional,_compound_and_subepithelial_conjunctival_naevi|Junctional, compound and subepithelial conjunctival naevi]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Inflamed_juvenile_conjunctival_naevus|Inflamed juvenile conjunctival naevus]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Blue_naevus_of_the_conjunctiva|Blue naevus of the conjunctiva]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:WNT-activated_deep_penetrating/plexiform_melanocytoma_(naevus)|WNT-activated deep penetrating/plexiform melanocytoma (naevus)]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Combined_naevus|Combined naevus]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Conjunctival_melanocytic_intraepithelial_lesions|Conjunctival melanocytic intraepithelial lesions]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Conjunctival_melanoma|Conjunctival melanoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | | | ||
+ | ==== CHAPTER 3 (TUMOURS OF THE EYELID) ==== | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | |- | ||
+ | |[[EYE5:Epidermal_inclusion_cyst|Epidermal inclusion cyst]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Intratarsal_cyst_|Intratarsal cyst]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Phakomatous_choristoma|Phakomatous choristoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Molluscum_contagiosum|Molluscum contagiosum]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Verruca_vulgaris|Verruca vulgaris]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Squamous_cell_papilloma|Squamous cell papilloma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Seborrheic_keratosis|Seborrheic keratosis]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Inverted_follicular_keratosis|Inverted follicular keratosis]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Actinic_keratosis|Actinic keratosis]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Basal_cell_carcinoma|Basal cell carcinoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Squamous_cell_carcinoma|Squamous cell carcinoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Merkel_cell_carcinoma|Merkel cell carcinoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Ductal_hidrocystoma|Ductal hidrocystoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Sebaceous_hyperplasia,_adenoma,_and_sebaceoma|Sebaceous hyperplasia, adenoma, and sebaceoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Syringoma|Syringoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Mixed_tumour|Mixed tumour]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Tubular_adenoma|Tubular adenoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Syringocystadenoma_papilliferum|Syringocystadenoma papilliferum]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Pilomatricoma|Pilomatricoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Trichilemmoma|Trichilemmoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Sebaceous_carcinoma|Sebaceous carcinoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Adenoid_cystic_carcinoma|Adenoid cystic carcinoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Signet-ring_cell/histiocytoid_carcinoma|Signet-ring cell/histiocytoid carcinoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Mucinous_carcinoma|Mucinous carcinoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Endocrine_mucin-producing_sweat_gland_carcinoma|Endocrine mucin-producing sweat gland carcinoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Microcystic_adnexal_carcinoma|Microcystic adnexal carcinoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Apocrine_carcinoma|Apocrine carcinoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Naevi_of_the_eyelid|Naevi of the eyelid]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Spitz_naevus|Spitz naevus]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:In-situ_cutaneous_melanoma|In-situ cutaneous melanoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Invasive_cutaneous_melanoma|Invasive cutaneous melanoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | | | ||
+ | ==== CHAPTER 4 (TUMOURS OF THE UVEAL TRACT) ==== | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | |- | ||
+ | |[[EYE5:Ectopic_tissue|Ectopic tissue]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Implantation_cyst|Implantation cyst]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Pigmented_epithelial_cyst|Pigmented epithelial cyst]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Lisch_nodule|Lisch nodule]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Ocular_melanocytosis|Ocular melanocytosis]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Iris_naevus|Iris naevus]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Iris_melanoma|Iris melanoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Choroidal_and_ciliary_body_naevi|Choroidal and ciliary body naevi]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Uveal_melanocytoma|Uveal melanocytoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Bilateral_diffuse_uveal_melanocytic_proliferation|Bilateral diffuse uveal melanocytic proliferation]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Choroidal_and_ciliary_body_melanomas|Choroidal and ciliary body melanomas]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | | | ||
+ | ==== CHAPTER 5 (TUMOURS OF THE RETINA AND NEUROEPITHELIUM) ==== | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | |- | ||
+ | |[[EYE5:Astrocytic_tumours|Astrocytic tumours]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Nodular_and_massive_retinal_gliosis|Nodular and massive retinal gliosis]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Retinocytoma|Retinocytoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Retinoblastoma|Retinoblastoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Hamartoma_of_the_retinal_pigment_epithelium|Hamartoma of the retinal pigment epithelium]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Congenital_hypertrophy_of_the_retinal_pigment_epithelium|Congenital hypertrophy of the retinal pigment epithelium]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Reactive_hyperplasia_of_the_retinal_pigment_epithelium|Reactive hyperplasia of the retinal pigment epithelium]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Adenoma_and_adenocarcinoma_of_the_retinal_pigment_epithelium|Adenoma and adenocarcinoma of the retinal pigment epithelium]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Reactive_epithelial_hyperplasia_of_the_ciliary_epithelium|Reactive epithelial hyperplasia of the ciliary epithelium]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Nodular_hyperplasia_of_the_ciliary_epithelium|Nodular hyperplasia of the ciliary epithelium]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Glioneuronal_hamartoma_of_the_ciliary_body|Glioneuronal hamartoma of the ciliary body]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Adenoma_and_adenocarcinoma_of_the_ciliary_body|Adenoma and adenocarcinoma of the ciliary body]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
| | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Medulloepithelioma_of_the_ciliary_body|Medulloepithelioma of the ciliary body]] | ||
|Disease | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
| | | | ||
| | | | ||
Line 27: | Line 928: | ||
| | | | ||
|- | |- | ||
− | |||
| | | | ||
+ | ==== CHAPTER 6 (TUMOURS OF THE OPTIC DISC AND OPTIC NERVE) ==== | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Optic_nerve_choristoma|Optic nerve choristoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 45: | Line 960: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Gliomas_of_the_optic_nerve|Gliomas of the optic nerve]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 54: | Line 971: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Medulloepithelioma_of_the_optic_disc_and_optic_nerve|Medulloepithelioma of the optic disc and optic nerve]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 63: | Line 982: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Meningioma_of_the_optic_nerve|Meningioma of the optic nerve]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 72: | Line 993: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Melanocytoma_of_the_optic_disc_and_optic_nerve|Melanocytoma of the optic disc and optic nerve]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 81: | Line 1,004: | ||
| | | | ||
|- | |- | ||
− | |||
| | | | ||
+ | ==== CHAPTER 7 (TUMOURS OF THE LACRIMAL GLAND) ==== | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Dacryops_cyst|Dacryops cyst]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 99: | Line 1,036: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Pleomorphic_adenoma_of_the_lacrimal_gland|Pleomorphic adenoma of the lacrimal gland]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 108: | Line 1,047: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Lacrimal_gland_oncocytoma|Lacrimal gland oncocytoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 117: | Line 1,058: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Myoepithelioma|Myoepithelioma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 126: | Line 1,069: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Intraductal_carcinoma|Intraductal carcinoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 135: | Line 1,080: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Carcinoma_ex_pleomorphic_adenoma|Carcinoma ex pleomorphic adenoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 144: | Line 1,091: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Adenoid_cystic_carcinoma|Adenoid cystic carcinoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 153: | Line 1,102: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Primary_ductal_adenocarcinoma_of_the_lacrimal_gland|Primary ductal adenocarcinoma of the lacrimal gland]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 162: | Line 1,113: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Secretory_carcinoma|Secretory carcinoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 171: | Line 1,124: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Mucoepidermoid_carcinoma|Mucoepidermoid carcinoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 180: | Line 1,135: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Epithelial-myoepithelial_carcinoma|Epithelial-myoepithelial carcinoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 189: | Line 1,146: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Acinic_cell_carcinoma|Acinic cell carcinoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 198: | Line 1,157: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Adenocarcinoma,_NOS|Adenocarcinoma, NOS]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 207: | Line 1,168: | ||
| | | | ||
|- | |- | ||
− | |||
| | | | ||
+ | ==== CHAPTER 8 (TUMOURS OF THE LACRIMAL DRAINAGE SYSTEM) ==== | ||
+ | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Papillomas_(squamous_and_inverted)|Papillomas (squamous and inverted)]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 225: | Line 1,200: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Squamous_cell_carcinoma|Squamous cell carcinoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 234: | Line 1,211: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Lymphoepithelial_carcinoma|Lymphoepithelial carcinoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 243: | Line 1,222: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Mucoepidermoid_carcinoma|Mucoepidermoid carcinoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 252: | Line 1,233: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Other_salivary_gland-type_carcinomas_of_the_lacrimal_drainage_system|Other salivary gland-type carcinomas of the lacrimal drainage system]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 261: | Line 1,244: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Adenocarcinoma_NOS_of_the_lacrimal_drainage_system|Adenocarcinoma NOS of the lacrimal drainage system]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 270: | Line 1,255: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Melanoma_involving_the_lacrimal_drainage_system|Melanoma involving the lacrimal drainage system]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 279: | Line 1,266: | ||
| | | | ||
|- | |- | ||
− | |||
| | | | ||
+ | ==== CHAPTER 9 (TUMOURS OF THE ORBIT) ==== | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Orbital_dermoid_cysts_and_other_orbital_cysts|Orbital dermoid cysts and other orbital cysts]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 297: | Line 1,298: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Cavernous_vascular_malformation|Cavernous vascular malformation]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 306: | Line 1,309: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Combined_lymphatic-venous_malformation_of_the_orbit|Combined lymphatic-venous malformation of the orbit]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 315: | Line 1,320: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Orbital_venous_malformation_|Orbital venous malformation]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 324: | Line 1,331: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Arteriovenous_malformation|Arteriovenous malformation]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 333: | Line 1,342: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Orbital_glial_heterotopia|Orbital glial heterotopia]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 342: | Line 1,353: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Mesenchymal_hamartoma_of_the_orbit|Mesenchymal hamartoma of the orbit]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 351: | Line 1,364: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Teratoma|Teratoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 360: | Line 1,375: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Yolk_sac_tumour|Yolk sac tumour]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 369: | Line 1,386: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Primary_orbital_melanoma|Primary orbital melanoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 378: | Line 1,397: | ||
| | | | ||
|- | |- | ||
− | |||
| | | | ||
+ | ==== CHAPTER 10 (HAEMATOLYMPHOID TUMOURS) ==== | ||
+ | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Reactive_lymphoid_hyperplasia|Reactive lymphoid hyperplasia]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 396: | Line 1,429: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:IgG4-related_disease|IgG4-related disease]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 405: | Line 1,440: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Primary_choroidal_lymphoma|Primary choroidal lymphoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 414: | Line 1,451: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Primary_vitreoretinal_large_B-cell_lymphoma|Primary vitreoretinal large B-cell lymphoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 423: | Line 1,462: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Extranodal_marginal_zone_lymphoma_|Extranodal marginal zone lymphoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 432: | Line 1,473: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Follicular_lymphoma|Follicular lymphoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 441: | Line 1,484: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Mantle_cell_lymphoma|Mantle cell lymphoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 450: | Line 1,495: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Chronic_lymphocytic_leukaemia/small_lymphocytic_lymphoma|Chronic lymphocytic leukaemia/small lymphocytic lymphoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 459: | Line 1,506: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Diffuse_large_B-cell_lymphoma_|Diffuse large B-cell lymphoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 468: | Line 1,517: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Plasmacytoma|Plasmacytoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 477: | Line 1,528: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:CD30_positive_lymphoproliferative_disorders|CD30 positive lymphoproliferative disorders]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 486: | Line 1,539: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:T-cell_lymphomas|T-cell lymphomas]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 495: | Line 1,550: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Extranodal_lymphoma_of_mature_NK_or_T-cell_lineage|Extranodal lymphoma of mature NK or T-cell lineage]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 504: | Line 1,561: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Extramedullary_myeloid_sarcoma|Extramedullary myeloid sarcoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 513: | Line 1,572: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Juvenile_xanthogranuloma|Juvenile xanthogranuloma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 522: | Line 1,583: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Rosai-Dorfman_disease|Rosai-Dorfman disease]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 531: | Line 1,594: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Erdheim-Chester_disease|Erdheim-Chester disease]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 540: | Line 1,605: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Langerhans_cell_tumours|Langerhans cell tumours]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 549: | Line 1,616: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Xanthelasma|Xanthelasma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 558: | Line 1,627: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Adult_orbital_xanthogranulomatous_disease|Adult orbital xanthogranulomatous disease]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 567: | Line 1,638: | ||
| | | | ||
|- | |- | ||
− | |||
| | | | ||
+ | ==== CHAPTER 11 (SOFT TISSUE AND BONE TUMOURS) ==== | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Conjunctival_stromal_tumour_and_ocular_surface_fibroma|Conjunctival stromal tumour and ocular surface fibroma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 585: | Line 1,670: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Fibrous_histiocytoma|Fibrous histiocytoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 594: | Line 1,681: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Nodular_and_proliferative_fasciitis,_proliferative_myositis|Nodular and proliferative fasciitis, proliferative myositis]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 603: | Line 1,692: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Solitary_fibrous_tumour|Solitary fibrous tumour]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 612: | Line 1,703: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 621: | Line 1,714: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Dermatofibrosarcoma_protuberans|Dermatofibrosarcoma protuberans]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 630: | Line 1,725: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Angiomyxoma|Angiomyxoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 639: | Line 1,736: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Benign_lipomatous_tumours|Benign lipomatous tumours]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 648: | Line 1,747: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Malignant_adipocytic_tumours|Malignant adipocytic tumours]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 657: | Line 1,758: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Rhabdomyosarcoma_family|Rhabdomyosarcoma family]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 666: | Line 1,769: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Leiomyoma|Leiomyoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 675: | Line 1,780: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Mesectodermal_leiomyoma|Mesectodermal leiomyoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 684: | Line 1,791: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Leiomyosarcoma|Leiomyosarcoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 693: | Line 1,802: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Schwannoma|Schwannoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 702: | Line 1,813: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Neurofibroma|Neurofibroma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 711: | Line 1,824: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Solitary_circumscribed_neuroma|Solitary circumscribed neuroma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 720: | Line 1,835: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Granular_cell_tumour|Granular cell tumour]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 729: | Line 1,846: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 738: | Line 1,857: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[EYE5:Masson_tumour|Masson tumour]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 747: | Line 1,868: | ||
| | | | ||
|- | |- | ||
+ | |[[EYE5:Infantile_haemangioma|Infantile haemangioma]] | ||
+ | |Disease | ||
+ | | | ||
| | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Lobular_capillary_haemangioma|Lobular capillary haemangioma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Lymphangiectasia|Lymphangiectasia]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Epithelioid_haemangioma|Epithelioid haemangioma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Haemangioblastoma|Haemangioblastoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Angiosarcoma|Angiosarcoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Glomus_tumour|Glomus tumour]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Myopericytoma,_including_myofibroma|Myopericytoma, including myofibroma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:PEComa|PEComa]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Epithelioid_sarcoma|Epithelioid sarcoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Synovial_sarcoma|Synovial sarcoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Alveolar_soft_part_sarcoma|Alveolar soft part sarcoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Osteoma|Osteoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Osteoblastoma|Osteoblastoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Osteosarcoma|Osteosarcoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Soft_tissue_chondroma|Soft tissue chondroma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Fibrous_dysplasia|Fibrous dysplasia]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Haemangioma_of_bone|Haemangioma of bone]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Epithelioid_haemangioendothelioma|Epithelioid haemangioendothelioma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Angiosarcoma_of_bone|Angiosarcoma of bone]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Aneurysmal_bone_cyst|Aneurysmal bone cyst]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Giant_cell_tumour_of_bone|Giant cell tumour of bone]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Ewing_sarcoma|Ewing sarcoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | | | ||
+ | ==== CHAPTER 12 (METASTASES TO THE EYE AND SURROUNDING STRUCTURES) ==== | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | |- | ||
+ | |[[EYE5:Metastases_to_ocular_adnexal_structures|Metastases to ocular adnexal structures]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Metastases_to_intra-ocular_structures|Metastases to intra-ocular structures]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | | | ||
+ | ==== CHAPTER 13 (GENETIC TUMOUR SYNDROMES) ==== | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | |- | ||
+ | |[[EYE5:Retinoblastoma_syndrome|Retinoblastoma syndrome]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Von_Hippel_Lindau_syndrome|Von Hippel Lindau syndrome]] | ||
+ | |Disease | ||
+ | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |- | ||
+ | |[[EYE5:Sturge_Weber_syndrome|Sturge Weber syndrome]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Neurofibromatosis_type_1_(NF1)|Neurofibromatosis type 1 (NF1)]] | ||
+ | |Disease | ||
+ | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |- | ||
+ | |[[EYE5:Goldenhar_syndrome|Goldenhar syndrome]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[EYE5:Muir-Torre_syndrome|Muir-Torre syndrome]] | ||
|Disease | |Disease | ||
| | | |
Latest revision as of 13:54, 10 September 2024
Welcome!
For assignments, please see the "Author" column below (highlighted blue).
If empty (no name is present), please volunteer to create content for that disease!
To volunteer, please [Contact us] with your page of interest.